title: Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward".
authors.affiliation: 1 Department of Neurosurgery, Otto-von-Guericke University Magdeburg , Magdeburg, Germany .
authors.forename: J Humberto
authors.initials: JH
authors.lastname: Tapia Pérez
authors.forename: Martin Sánchez
authors.initials: MS
authors.lastname: Aguilar
authors.forename: Thomas
authors.initials: T
authors.lastname: Schneider
mesh_terms: D000647:Amnesia / Q000517:prevention & control*; D035843:Biomedical Research / Q000592:standards*; D001930:Brain Injuries / Q000188:drug therapy* / Q000523:psychology*; D003221:Confusion / Q000517:prevention & control*; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009480:Neuropharmacology / Q000592:standards*; D011743:Pyrimidines / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D059030:United States Department of Defense / Q000592:standards*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides